**Core tip**: In this study, we aimed to determine whether the long noncoding RNAs LINC00511 exerted its carcinogenic function in gastric cancer (GC) *via* the miR-124-3p/PDK4 axis. First, we investigated the expression level of LINC00511 in GC cell lines, and we then examined the biological function of LINC00511 with functional assays. Next, we predicted and confirmed the interaction between LINC00511 and miR-124-3p. Furthermore, we further found that PDK4 was a downstream target of miR-124-3p. Finally, we concluded that LINC00511 plays an oncogenic role in GC by sponging miR-124-3p and targeting PDK4, indicating that LINC00511 may be a new molecular biomarker for GC.

INTRODUCTION
============

Gastric cancer (GC), as a kind of heterogeneous disease in the digestive system, has been steadily increasing worldwide\[[@B1],[@B2]\]. The overall survival rate of GC patients is poor\[[@B3]\]. Therefore, it is necessary to identify potential biomarkers of GC and to study their molecular regulatory mechanisms to provide patients with better therapeutic outcomes.

Long noncoding RNAs (lncRNAs), a group of RNAs that are 200 nucleotides long, do not have protein-coding and translational capacity\[[@B2],[@B4],[@B5]\]. Increasing evidence has demonstrated that the dysregulation of lncRNA expression plays a crucial role in the pathogenesis of many cancers, including in cell proliferation and apoptosis\[[@B6]\]. For instance, the upregulation of the long noncoding RNA SNHG6 promotes cell malignancy in esophageal squamous cell carcinoma\[[@B7]\]. The long noncoding RNA LINC01296 induces non-small cell lung cancer growth and progression by sponging miR-5095\[[@B8]\]. The long noncoding RNA NEAT1 plays an oncogenic role in triple-negative breast cancer by modulating chemoresistance and cancer stemness\[[@B9]\]. A recent study found that the lncRNA LINC00511 contributes to breast cancer tumorigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis\[[@B10]\]. The knockdown of the long noncoding RNA LINC00511 suppresses the proliferation and promotes the apoptosis of bladder cancer cells by suppressing the Wnt/β-catenin signaling pathway\[[@B11]\]. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2\[[@B12]\]. However, the specific biological function and regulatory mechanism of LINC00511 in GC have not been extensively explored.

In this study, we aimed to determine whether the lncRNA LINC00511 exerted its carcinogenic function in GC *via* the miR-124-3p/PDK4 axis. First, we investigated the expression level of LINC00511 in GC cell lines, and we then examined the biological function of LINC00511 with functional assays. Next, we predicted and confirmed the interaction between LINC00511 and miR-124-3p. Furthermore, we further found that PDK4 was a downstream target of miR-124-3p. Finally, we concluded that LINC00511 plays an oncogenic role in GC by sponging miR-124-3p and targeting PDK4, indicating that LINC00511 may be a new molecular biomarker for GC.

MATERIALS AND METHODS
=====================

Cell culture and transfection
-----------------------------

GC cell lines (MKN-45, BGC-823, HGC-27, and MGC-803) and healthy human gastric epithelial cells (GES-1) were obtained from the American Type Culture Collection (ATCC; Manassas, VA, United States) and were cultured in Roswell Park Memorial Institute 1640 medium containing 10% fetal bovine serum (FBS; Gibco/Invitrogen Inc., Carlsbad, CA, United States), streptomycin (100 mg/ml), and penicillin (100 U/mL). All of these cells were cultivated at 37°C, with 5% CO~2~ in a humid atmosphere.

Short hairpin RNAs (shRNAs) specifically targeting LINC00511 were designed and synthesized to knockdown LINC00511. LINC00511 and PDK4 were overexpressed with pcDNA3.1 vectors. MiR-124-3p mimics and inhibitors were used for miR-124-3p overexpression and silencing, respectively. In addition, NC mimics and an NC inhibitor were used as negative controls. All the plasmids mentioned above were purchased from GenePharma (Shanghai, China), and they were transfected into MKN-45 and MGC-803 cells by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, United States) in accordance with the manufacturer's recommendations.

RNA extraction and quantitative real-time PCR
---------------------------------------------

Total RNA was extracted from MKN-45 and MGC-803 cells with Trizol reagent (Takara, Otsu, Japan). A TaqMan^TM^ Advanced miRNA cDNA Synthesis Kit (Waltham, MA, United States) or a reverse transcription kit (Takara, Otsu, Japan) was utilized to reverse transcribe the RNAs into cDNA. An quantitative real-time PCR (RT-qPCR) assay was performed with an SYBR Green PCR Kit (Takara, Otsu, Japan). GAPDH and U6 were utilized as internal controls. An Applied Biosystems Step One Plus Real-Time PCR System (Applied Biosystems, Foster City, United States) was used to analyze the results. In addition, the relative expression levels were examined with the 2^−ΔΔCt^ method.

CCK-8 assay
-----------

To investigate the proliferation of the gastric cancer cells, a Cell-Counting Kit 8 (CCK8; Dojindo Molecular Technologies) was used. The transfected cells (1 × 10^4^ cells/well) were seeded in 96-well plates and then cultured for 24, 48, 72, and 96 h. Then, 10 μL CCK-8 solution was added to each well, and the cells were incubated for another 4 h. The absorbance at 450 nm was measured by using a Multiskan Go spectrophotometer (Thermo Fisher Scientific, Inc.).

Colony formation assay
----------------------

Transfected cells (1 × 10^3^ cells/well) were seeded into 6-well plates and maintained in Roswell Park Memorial Institute 1640 medium that was replaced every 3 d. Two weeks later, PBS was used to wash the cells, and then the cells were fixed with methanol and stained with crystal violet. Subsequently, the colonies were visualized and could be counted.

Luciferase reporter assay
-------------------------

The 3′-UTR sequences of PDK4, containing the predicted binding sites for miR-124-3p, and the full-length sequences of LINC00511 were subcloned into pGL3 vectors (Promega, Madison, WI, United States); thus, the wild-type PDK4 reporter (PDK4-Wt) and the wild-type LINC00511 reporter (LINC00511-Wt) were produced. The mutant-type PDK4 reporter (PDK4-Mt) and the mutant-type LINC00511 reporter (LINC00511-Mt) were built in the same manner. The miR-124-3p mimic or miR-NC was cotransfected with LINC00511-Wt or LINC00511-Mut into MKN-45 or MGC-803 cells by using Lipofectamine 2000. MiR-124-3p mimics, or miR-NC, were also cotransfected with PDK4-Wt or PDK4-Mut into MKN-45 or MGC-803 cells. Forty-eight hours later, a luciferase reporter assay system (Promega, Madison WI, United States) was used to measure the luciferase activities.

RIP assay
---------

A Magna RNA-binding protein immunoprecipitation kit (Millipore, Billerica, MA, United States) was utilized to conduct the RIP assay. Cell lysates (MKN-45 and MGC-803) were mixed with RIP buffer containing anti-Ago2-conjugated beads. Input and IgG were used as positive and negative controls, respectively. Immunoprecipitated RNAs were isolated with proteinase K, and RT-qPCR was used to detect the purified RNAs.

RNA pull-down assay
-------------------

To further probe the binding capacity of LINC00511 and miR-124-3p, a pull-down assay was conducted. First, LINC00511 and NC were biotinylated to generate a Bio-LINC00511-Probe and Bio-NC-Probe by GenePharma Company (Shanghai, China). The Bio-LINC00511-Probe and Bio-NC-Probe were transfected into MKN-45 and MGC-803 cells. Then, biotinylated RNAs and cell lysates were cultured with streptavidin-coupled beads for 48 h. Finally, the expression of the purified RNA complexes was detected by RT-qPCR.

Western blot analysis
---------------------

Total proteins were extracted by using RIPA lysis buffer (Beyotime Biotechnology, China) to which protease inhibitors (Roche, China) were added. A BCA^TM^ Protein Assay Kit (Pierce, Appleton, United States) was used to measure the protein concentration. Proteins were separated by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After electrophoresis, the proteins were transferred onto polyvinylidene difluoride membranes, and then the membranes were blocked with skim milk and were incubated with primary antibodies at 4°C. Later, the membranes were incubated with secondary antibody for 1 h at 37°C. Protein expression was detected with a chemiluminescent detection system.

Statistical analysis
--------------------

SPSS 20.0 software (SPSS, Chicago, IL, United States) was used for statistical analysis. Data are presented as the mean ± SD. Differences among groups were analyzed by one-way ANOVA or a Student\'s *t*-test. Each experiment was conducted three times. A value of *P* \< 0.05 was considered to be significant.

RESULTS
=======

LINC00511 expression is upregulated in GC, promoting cell proliferation but suppressing cell apoptosis
------------------------------------------------------------------------------------------------------

Multiple reports have demonstrated that LINC00511 is high expression in various cancers and that LINC00511 can accelerate tumorigenesis\[[@B10],[@B12],[@B13]\]. Nevertheless, whether LINC00511 can also promote tumorigenesis in GC remains unknown. Based on a qRT-PCR assay, we found that the expression of LINC00511 in MKN-45, BGC-823, HGC-27, and MGC-803 cells was clearly higher than that in GES-1 (Figure [1A](#F1){ref-type="fig"}). Moreover, a significant decrease in LINC00511 expression was observed in MKN-45, and MGC-803 cells that had been transfected with si-LINC00511\#1, si-LINC00511\#2 and si-LINC00511\#3 (Figure [1B](#F1){ref-type="fig"}) compared to that of the controls. Additionally, cell proliferation was clearly decreased in MKN-45 and MGC-803 cells the si-LINC00511 group compared with that in the cells that had been transfected with the scrambled control (Figure [1C](#F1){ref-type="fig"}). A colony formation assay was performed. We found that the number of countable colonies in the si-LINC00511 group was lower than that in the scramble control group for the MKN-45 and MGC-803 cells (Figure [1D](#F1){ref-type="fig"}). Based on a Western blot assay, the expression of Cleaved-Caspase 3 was increased by knocking down LINC00511 compared to that in the controls, which meant that the LINC00511 knockdown promoted apoptosis in the MKN-45 and MGC-803 cell lines (Figure [1E](#F1){ref-type="fig"}). In summary, LINC00511 is highly expressed in GC cells, promoting cell proliferation and limiting cell apoptosis.

![LINC00511 expression is upregulated and promotes gastric cancer cell growth. A: Quantitative real-time PCR, analysis was performed to detect the expression of LINC00511 in normal gastric cells and gastric cancer (GC) cells; B: Quantitative real-time PCR, analysis was conducted to examine the knockdown efficiency of si-LINC00511\#1/2/3; C, D: CCK-8 and colony formation assays were used to measured cell proliferation after the knockdown of LINC00511 in GC cells; E: A cell apoptosis-related protein (Caspase 3) was assessed by WB assay. ^a^*P* \< 0.05, ^b^*P*\< 0.01.](WJGO-12-394-g001){#F1}

MiR-124-3p expression is downregulated in GC, inhibiting cell proliferation but accelerating cell apoptosis
-----------------------------------------------------------------------------------------------------------

Although miR-124-3p has been reported to suppress tumorigenesis in colorectal cancer\[[@B14],[@B15]\], the biological function of miR-124-3p in GC has not yet been reported. First, the qRT-PCR results indicated that miR-124-3p expression was downregulated in GC cell lines (MKN-45, BGC-823, HGC-27, and MGC-803) (Figure [2A](#F2){ref-type="fig"}) compared to that in other cell types. Then, miR-124-3p mimics were transfected into MKN-45 and MGC-803 cells, and miR-NC was used as a scrambled control. We found that miR-124-3p expression was remarkably increased by miR-124-3p mimics in MKN-45 and MGC-803 cells (Figure [2B](#F2){ref-type="fig"}) compared to that in the controls. Finally, we noticed that miR-124-3p overexpression limited proliferation but accelerated apoptosis in MKN-45 and MGC-803 cells (Figure [2C-E](#F2){ref-type="fig"}) compared to those in the controls. In conclusion, miR-124-3p is downregulated in GC, which prevents cell proliferation and accelerates cell apoptosis.

![MiR-124-3p is downregulated in gastric cancer and inhibits cell growth. A: The relative expression of miR-124-3p in normal gastric cells and gastric cancer (GC) cells was analyzed by quantitative real-time PCR; B: The overexpression efficiency of miR-124-3p mimics was measured with quantitative real-time PCR; C, D: The effect of miR-124-3p overexpression on cell proliferation in GC cells was investigated by CCK-8 and colony formation assays; E: WB assay was used to examine the protein levels of cleaved caspase-3 and total caspase-3. ^a^*P* \< 0.05, ^b^*P* \< 0.01.](WJGO-12-394-g002){#F2}

LINC00511 acts as a sponge for miR-124-3p in GC
-----------------------------------------------

According to the starBase database, miR-124-3p contains binding sites for LINC00511 (Figure [3A](#F3){ref-type="fig"}), and miR-124-3p was reported to function as a tumor suppressor in non-small cell lung cancer\[[@B16]\]. Hence, miR-124-3p was chosen for further exploration. To analyze the relationship between LINC00511 and miR-124-3p, the following assays were performed. Initially, the qRT-PCR assay was used to demonstrate that the expression of miR-124-3p was higher in si-LINC00511-transfected cells than in the scrambled control cells (Figure [3B](#F3){ref-type="fig"}). Then, a luciferase assay showed that the luciferase activity of pGL3-LINC00511-Wt was prominently reduced in MKN-45 and MGC-803 cells transfected with miR-124-3p mimics compared to that in the controls. However, no apparent change in luciferase activity was observed in the pGL3-LINC00511-Mut group, indicating that LINC00511 could bind miR-124-3p (Figure [3C](#F3){ref-type="fig"}). Additionally, the RIP assay revealed that LINC00511 and miR-124-3p could be coimmuno-precipitated by anti-Ago2 but not with anti-IgG (Figure [3D](#F3){ref-type="fig"}). Last but not least, compared to Bio-NC-Probe, higher expression of miR-124-3p in the Bio-LINC00511 Probe group was observed in MKN-45 and MGC-803 cells (Figure [3E](#F3){ref-type="fig"}). These experimental results confirmed that LINC00511 could bind miR-124-3p, negatively modulating the expression of miR-124-3p in GC.

![MiR-124-3p can bind LINC00511. A: The potential binding site between miR-124-3p and LINC00511 was predicted by the starBase v2.0 software; B: Quantitative real-time PCR was used to assess the expression level of miR-124-3p after the knockdown of LINC00511; C, D: RIP and luciferase reporter assays were used to confirm the interaction between miR-124-3p and LINC00511; E: The RNA pull-down assay suggested the direct interaction of miR-124-3p and LINC00511. ^a^*P* \< 0.05, ^b^*P* \< 0.01.](WJGO-12-394-g003){#F3}

LINC00511 regulates PDK4 expression by competing for binding with miR-124-3p
----------------------------------------------------------------------------

An increasing number of reports have shown that PDK4 functions as an oncogene in a variety of cancers\[[@B17]-[@B19]\], but its expression status in GC remains unclear. Obviously, higher expression of PDK4 was observed in MKN-45, BGC-823, HGC-27, and MGC-803 cell lines (Figure [4A](#F4){ref-type="fig"}) compared to that in other types of cells. As shown in Figure [4B](#F4){ref-type="fig"}, the overexpression of miR-124-3p clearly downregulated the expression of PDK4 in MKN-45 and MGC-803 cells compared to that in the controls. Western blot assays verified that miR-124-3p overexpression prevented the protein expression of PDK4 in MKN-45 and MGC-803 cells (Figure [4C](#F4){ref-type="fig"}). The StarBase database was utilized to identify potential target genes, and we found that PDK4 could bind miR-124-3p (Figure [4D](#F4){ref-type="fig"}). Figure [4E](#F4){ref-type="fig"} shows that the luciferase activity of the LINC00511-Wt vectors was prominently reduced in 293T cells that were transfected with miR-124-3p mimics compared to that in the controls. However, no obvious change in luciferase activity was observed in the group of LINC00511-Mut vectors, which suggested that LINC00511 could bind miR-124-3p (Figure [4E](#F4){ref-type="fig"}). Finally, Western blot analysis showed that miR-124-3p inhibitors reversed the inhibition of PDK4 that was induced by LINC00511 knockdown (Figure [4F](#F4){ref-type="fig"}) in MGC-803 cells. Taken together, LINC00511 competes with binding with miR-124-3p to regulate PDK4 expression.

![PDK4 is a downstream target of miR-124-3p. A: The expression level of PDK4 in gastric cancer (GC) cells and normal gastric cells was determined by quantitative real-time PCR; B, C: Quantitative real-time PCR and WB assays were utilized to examine the expression level of PDK4 after miR-124-3p overexpression; D: The binding site of miR-124-3p and PDK4 was predicted with starBase v2.0; E: A luciferase reporter assay was used to verify that miR-124-3p could sponge PDK4; F: WB assay showed that LINC00511 silencing resulted in a reduction of PDK4 protein levels, which was partly rescued by miR-124-3p inhibition. ^a^*P* \< 0.05, ^b^*P* \< 0.01.](WJGO-12-394-g004){#F4}

LINC00511 drives GC cell growth by acting as a ceRNA to regulate the miR-124-3p/PDK4 axis
-----------------------------------------------------------------------------------------

To confirm whether LINC00511 acts as a ceRNA in GC, rescue assays were performed. PDK4 expression was conspicuously increased in MGC-803 cells transfected with pcDNA3.1-PDK4 compared that in cells that had been transfected with the scrambled control (Figure [5A](#F5){ref-type="fig"}). The CCK-8 assay and colony formation assay demonstrated that PDK4 overexpression or miR-124-3p downregulation partially reversed the inhibitory effects of LINC00511 knockdown on cell proliferation (Figure [5B and C](#F5){ref-type="fig"}). Finally, the promotion of apoptosis that was caused by LINC00511 knockdown was partially counteracted by the overexpression of PDK4 or the downregulation of miR-124-3p (Figure [5D](#F5){ref-type="fig"}). Collectively, these results revealed that LINC00511 facilitates GC cell growth by regulating the miR-124-3p/PDK4 axis.

![LINC00511 promotes gastric cancer cell growth by regulating PDK4 expression. A: Quantitative real-time PCR was employed to explore the mRNA levels of PDK4 in GC cells transfected with pcDNA3.1/PDK4; B, C: Cell proliferation ability was examined by CCK-8 and colony formation assays; D: WB assay was used to examine the protein level of cleaved caspase-3 and total caspase-3. ^a^*P* \< 0.05, ^b^*P* \< 0.01.](WJGO-12-394-g005){#F5}

DISCUSSION
==========

Numerous studies have revealed that lncRNAs influence the progression of different kinds of cancers, such as bladder cancer, lung cancer, hepatocellular carcinoma, and esophageal squamous cell carcinoma\[[@B7],[@B20]-[@B23]\]. It has been reported that the lncRNA LINC00511 contributes to tumorigenesis and tumor progression in breast cancer by enhancing the miR-185-3p/E2F1/Nanog axis\[[@B10]\]. The long noncoding RNA LINC00511 promotes proliferation and suppresses apoptosis of bladder cancer cells via the Wnt/β-catenin signaling pathway\[[@B11]\]. LINC00511 modulates tongue squamous cell carcinoma progression by interacting with miR-765 to regulate LAMC2 expression\[[@B12]\]. Nevertheless, the biological function and molecular regulatory mechanisms of LINC00511 in GC remain unclear. In our study, we found that LINC00511 was more highly expressed in GC cell lines than in corresponding normal cell lines. Furthermore, the knockdown of LINC00511 inhibited cell proliferation while promoting cell apoptosis. All of these data indicated that LINC00511 promoted the progression of GC.

MircoRNAs (miRNAs) are a class of short noncoding RNAs containing\[[@B20]-[@B24]\] nucleotides that play significant roles in the post-transcriptional regulation of the expression of genes\[[@B24],[@B25]\]. Recently, it has been reported that lncRNAs modulate some diseases by acting as sponges to combine with miRNAs. For example, the long noncoding RNA LINC00202 promotes tumor progression by sponging miR-3619-5p in retinoblastoma\[[@B26]\]. AC016405.3, a novel lncRNA, acts as a tumor suppressor by modulating TET2 through miR-19a-5p sponging in glioblastoma\[[@B27]\]. LINC00511 promotes the progression of tongue squamous cell carcinoma by interacting with miR-765\[[@B12]\]. However, the interaction of LINC00511 with its downstream miRNA in GC cells remains to be examined. In this study, we identified miR-124-3p as a potential target miRNA that could bind with LINC00511 with starBase. According to previous studies, miR-124-3p has antitumor effects in various cancers\[[@B28]-[@B30]\]. In our study, we further confirmed that LINC00511 could bind miR-124-3p and negatively modulate the expression of miR-124-3p in GC. All of these data indicated that LINC00511 sponged miR-124-3p to regulate GC progression.

PDK4 is reported to have an oncogenic effect in many human cancers\[[@B18],[@B31]\]. The overexpression of PDK4 is associated with cell proliferation, drug resistance, and poor prognosis in ovarian cancer\[[@B18]\]. The loss of PDK4 switches the hepatic NF-κB/TNF pathway from having a prosurvival effect to having a pro-apoptosis impact\[[@B31]\]. It was predicted that PDK4 could bind with miR-124-3p based upon bioinformatics analysis. We found that miR-124-3p could bind PDK4 to regulate PDK4 expression negatively. Lastly, rescue assays demonstrated that the overexpression of PDK4 or the inhibition of miR-124-3p could partially rescue the effects of LINC00511 knockdown on cell proliferation and apoptosis.

In summary, our study showed that LINC00511 promotes the tumorigenesis and development of GC by targeting miR-124-3p/PDK4, indicating the potential of the LINC00511/miR-124-3p/PDK4 axis as a new biomarker for GC prognosis.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

It has been reported that LINC00511 contributes to tumorigenesis in various diseases. However, the role of LINC00511 in gastric cancer (GC) cell growth remains mostly unknown.

Research motivation
-------------------

The specific biological function and regulatory mechanism of LINC00511 in GC have not been extensively explored.

Research objectives
-------------------

In this study, the authors aimed to determine whether the long noncoding RNAs LINC00511 exerted its carcinogenic function in GC *via* the miR-124-3p/PDK4 axis.

Research methods
----------------

The cell culture and transfection, RNA extraction and quantitative real-time PCR, CCK-8 assay, Colony formation assay, Luciferase reporter assay, RIP assay, RNA pull-down assay, and Western blot analysis were used to show expression and mechanisms of LINC00511 in GC progression and apoptosis. Rescue assays were performed to verify the relationships among LINC00511, miR-124-3p and PDK4 further.

Research results
----------------

The expression of LINC00511 was remarkably upregulated in GC cells compared to that in corresponding normal cell lines. Compared to the controls, cell proliferation was inhibited, and cell apoptosis was increased upon LINC00511 knockdown, demonstrating that LINC00511 influenced GC cell growth. An exploration of the molecular mechanism revealed that LINC00511 functioned as a molecular sponge of miR-124-3p and that PDK4 was a downstream target of miR-124-3p in GC.

Research conclusions
--------------------

The results of the study demonstrate that LINC00511 promotes gastric cancer cell growth by acting as a ceRNA to regulate the miR-124-3p/PDK4 axis, which may be a promising therapeutic target for GC.
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